New shoulder implant aims to cut Re-Tear rates after rotator cuff surgery

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult, 21 years and older; 2. Patient with a diagnosis of a symptomatic primary partial-thickness or full-thickness tear of the supraspinatus and/or infraspinatus tendons amenable to repair that meets one of the following criteria: * Partial-thickness tear planned for standalone treatment (no surgical repair with sutures/suture anchors) with the Tapestry Biointegrative Implant, or * Full-thickness tear planned for treatment with the Tapestry Biointegrative Implant as an adjunct to surgical repair (single or double row repair with sutures/suture anchors); 3. Patient is able and willing to complete the protocol required follow-up; 4. Patient is able and willing to sign the IRB approved informed consent; 5. Independent of study participation, patient qualifies for arthroscopic rotator cuff repair and meets the approved indications for use of the commercially available Tapestry RC Biointegrative Implant System Exclusion Criteria: 1. Hypersensitivity to bovine-derived materials or poly(D,L-lactide) materials; 2. Patient with an irreparable or partially reparable rotator cuff tear; 3. Revision rotator cuff repair; 4. Off-label use of the study device; 5. Patient is known to be pregnant or nursing; 6. Patient is a prisoner; 7. Patient is a known alcohol or drug abuser; 8. Patient has a psychiatric illness, neurologic disorder, or cognitive deficit that will not allow for proper informed consent or compliance with study requirements; 9. Patient is unable to tolerate magnetic resonance imaging (MRI), due to psychiatric or medical contraindications; 10. Patient is unwilling or unable to give consent or to comply with the follow-up program; 11. Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.